0.96
0.96 (-2.54%)
As of Mar 06, 2024
Monopar Therapeutics [MNPR]
Source:
Company Overview
Monopar Therapeutics is a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve quality of life for cancer patients. We are building a drug development pipeline through the licensing and acquisition of therapeutics in late preclinical and clinical development stages.
Country | United States |
Headquarters | wilmette, illinois |
Phone Number | 8473880349 |
Industry | manufacturing |
CEO | Chandler Robinson |
Website | www.monopartx.com |